nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Abacavir—Myocardial infarction—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Abacavir—Malaise—Prednisolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Abacavir—Vertigo—Prednisolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Abacavir—Convulsion—Prednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Abacavir—Pancreatitis—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Abacavir—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Abacavir—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Abacavir—Alopecia—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Abacavir—Alopecia—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Abacavir—Discomfort—Prednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Abacavir—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Abacavir—Malaise—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Abacavir—Malaise—Methylprednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Abacavir—Vertigo—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Abacavir—Vertigo—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Abacavir—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Abacavir—Oedema—Prednisolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Abacavir—Cough—Triamcinolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Abacavir—Convulsion—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Abacavir—Convulsion—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Abacavir—Myalgia—Triamcinolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Abacavir—Myalgia—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Abacavir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Abacavir—Anxiety—Methylprednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Abacavir—Depression—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Abacavir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Abacavir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Abacavir—Discomfort—Triamcinolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Abacavir—Discomfort—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Abacavir—Renal failure—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Abacavir—Immune system disorder—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Abacavir—Malaise—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Malaise—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Oedema—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Vertigo—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Vertigo—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Abacavir—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Abacavir—Infection—Triamcinolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Abacavir—Infection—Methylprednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Abacavir—Insomnia—Prednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Abacavir—Alopecia—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Abacavir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Abacavir—Paraesthesia—Prednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Abacavir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Abacavir—Malnutrition—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Abacavir—Convulsion—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Abacavir—Convulsion—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Abacavir—Myalgia—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Abacavir—Myalgia—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Abacavir—Anxiety—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Abacavir—Anxiety—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Abacavir—Discomfort—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Abacavir—Discomfort—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Abacavir—Hypotension—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Abacavir—Pain—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Oedema—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Oedema—Betamethasone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Abacavir—Insomnia—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Abacavir—Insomnia—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Abacavir—Infection—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Abacavir—Infection—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Abacavir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Abacavir—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Abacavir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Abacavir—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Abacavir—Anaemia—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Abacavir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Abacavir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Abacavir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Abacavir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Abacavir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Abacavir—Malaise—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Abacavir—Vertigo—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Abacavir—Anorexia—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Abacavir—Anorexia—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Abacavir—Urticaria—Prednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Abacavir—Fatigue—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Abacavir—Fatigue—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Abacavir—Pain—Triamcinolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Abacavir—Hypotension—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Abacavir—Hypotension—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Abacavir—Convulsion—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Abacavir—Chills—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Myalgia—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Arthralgia—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Anxiety—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Alopecia—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Abacavir—Insomnia—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Abacavir—Insomnia—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Abacavir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Abacavir—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Abacavir—Paraesthesia—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Abacavir—Discomfort—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Abacavir—Urticaria—Triamcinolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Abacavir—Urticaria—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Abacavir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Oedema—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Decreased appetite—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Abacavir—Infection—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Abacavir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Abacavir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Abacavir—Fatigue—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Abacavir—Fatigue—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Abacavir—Pain—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Abacavir—Pain—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Abacavir—Skin disorder—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Abacavir—Anorexia—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Abacavir—Anaemia—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Abacavir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Abacavir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Abacavir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Abacavir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Abacavir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Abacavir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Abacavir—Malaise—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Abacavir—Vertigo—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Abacavir—Urticaria—Dexamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Abacavir—Urticaria—Betamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Abacavir—Dizziness—Prednisolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Abacavir—Asthenia—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Abdominal pain—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Body temperature increased—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Asthenia—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Insomnia—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Abacavir—Paraesthesia—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Abacavir—Pruritus—Triamcinolone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Abacavir—Cough—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Abacavir—Pruritus—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Abacavir—Convulsion—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Myalgia—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Rash—Prednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Abacavir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Abacavir—Fatigue—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Abacavir—Headache—Prednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Abacavir—Discomfort—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Abacavir—Dizziness—Triamcinolone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Abacavir—Dizziness—Methylprednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Abacavir—Infection—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Abacavir—Feeling abnormal—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Abacavir—Asthenia—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Abacavir—Asthenia—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Abacavir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Abacavir—Nausea—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Abacavir—Pruritus—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Abacavir—Pruritus—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Abacavir—Vomiting—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Abacavir—Vomiting—Methylprednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Abacavir—Rash—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Dermatitis—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Anorexia—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Rash—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Urticaria—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Headache—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Abacavir—Headache—Methylprednisolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Abacavir—Diarrhoea—Betamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Abacavir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Abacavir—Hypotension—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Abacavir—Dizziness—Dexamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Abacavir—Dizziness—Betamethasone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Abacavir—Insomnia—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Abacavir—Nausea—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Abacavir—Nausea—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Abacavir—Hypersensitivity—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Abacavir—Vomiting—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Abacavir—Vomiting—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Abacavir—Rash—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Abacavir—Rash—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Abacavir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Abacavir—Dermatitis—Betamethasone—psoriatic arthritis	0.000999	0.000999	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000997	0.000997	CcSEcCtD
Abacavir—Fatigue—Methotrexate—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Abacavir—Headache—Dexamethasone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Abacavir—Headache—Betamethasone—psoriatic arthritis	0.000994	0.000994	CcSEcCtD
Abacavir—Asthenia—Prednisone—psoriatic arthritis	0.000991	0.000991	CcSEcCtD
Abacavir—Pain—Methotrexate—psoriatic arthritis	0.000987	0.000987	CcSEcCtD
Abacavir—Pruritus—Prednisone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000951	0.000951	CcSEcCtD
Abacavir—Diarrhoea—Prednisone—psoriatic arthritis	0.000945	0.000945	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000944	0.000944	CcSEcCtD
Abacavir—Nausea—Betamethasone—psoriatic arthritis	0.000942	0.000942	CcSEcCtD
Abacavir—Nausea—Dexamethasone—psoriatic arthritis	0.000942	0.000942	CcSEcCtD
Abacavir—Urticaria—Methotrexate—psoriatic arthritis	0.000917	0.000917	CcSEcCtD
Abacavir—Dizziness—Prednisone—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Abacavir—Vomiting—Prednisone—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Abacavir—Rash—Prednisone—psoriatic arthritis	0.000871	0.000871	CcSEcCtD
Abacavir—Dermatitis—Prednisone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Abacavir—Headache—Prednisone—psoriatic arthritis	0.000865	0.000865	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Abacavir—Asthenia—Methotrexate—psoriatic arthritis	0.000828	0.000828	CcSEcCtD
Abacavir—Nausea—Prednisone—psoriatic arthritis	0.00082	0.00082	CcSEcCtD
Abacavir—Pruritus—Methotrexate—psoriatic arthritis	0.000817	0.000817	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—psoriatic arthritis	0.00079	0.00079	CcSEcCtD
Abacavir—Dizziness—Methotrexate—psoriatic arthritis	0.000763	0.000763	CcSEcCtD
Abacavir—Vomiting—Methotrexate—psoriatic arthritis	0.000734	0.000734	CcSEcCtD
Abacavir—Rash—Methotrexate—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—psoriatic arthritis	0.000727	0.000727	CcSEcCtD
Abacavir—Headache—Methotrexate—psoriatic arthritis	0.000723	0.000723	CcSEcCtD
Abacavir—Nausea—Methotrexate—psoriatic arthritis	0.000686	0.000686	CcSEcCtD
